Fulcrum Therapeutics (FULC) Change in Receivables (2020 - 2025)
Fulcrum Therapeutics' (FULC) quarterly Change in Receivables came in at -$979000.0 in Q2 2025, down 141.96% year-on-year from $2.3 million in Q2 2024, and up 12.35% on a QoQ basis from -$1.1 million in Q1 2025.
Fulcrum Therapeutics (FULC) Change in Receivables (2020 - 2025) Analysis & Trends
Fulcrum Therapeutics (FULC) has 6 years of Change in Receivables data on file, last reported at -$979000.0 in Q2 2025.
- On a quarterly basis, Change in Receivables fell 141.96% year-over-year to -$979000.0 in Q2 2025; TTM through Mar 2026 was -$979000.0, a 200.0% decrease from a year earlier, with the FY2025 full-year figure at -$2.1 million, down 234.45% from the prior year.
- Change in Receivables for Q2 2025 stood at -$979000.0, up from -$1.1 million in the prior quarter.
- Over the last five years, Change in Receivables for FULC reached as high as $2.5 million in Q4 2021 and fell as low as -$3.4 million in Q4 2022.
- Historically, Change in Receivables has averaged -$37470.6 across 5 years, with a median of -$43000.0 in 2023.
- Across the five-year window, Change in Receivables jumped 33400.0% in 2022 and plunged 3527.91% in 2024, its largest moves.
- Year by year, Change in Receivables stood at $2.5 million in 2021, then slumped by 235.8% to -$3.4 million in 2022, then jumped by 98.73% to -$43000.0 in 2023, then plunged by 3527.91% to -$1.6 million in 2024, then soared by 37.24% to -$979000.0 in 2025.
- Per Business Quant data, the three most recent Change in Receivables figures were -$979000.0 in Q2 2025, -$1.1 million in Q1 2025, and -$1.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fulcrum Therapeutics | 286.57 Mn | 286.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -979,000.00 |
| Jun 30, 2025 | -979,000.00 |
| Mar 31, 2025 | -1.12 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -1.56 Mn |
| Dec 31, 2024 | -1.56 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | -537,000.00 |
| Mar 31, 2024 | -537,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Sep 30, 2023 | -76,000.00 |
| Sep 30, 2023 | -76,000.00 |
| Jun 30, 2023 | 557,000.00 |
| Jun 30, 2023 | 557,000.00 |
| Mar 31, 2023 | -130,000.00 |
| Mar 31, 2023 | -130,000.00 |